Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.
| dc.contributor.author | Ursem, Carling J | |
| dc.contributor.author | Bosworth, Hayden B | |
| dc.contributor.author | Shelby, Rebecca A | |
| dc.contributor.author | Hwang, Wenke | |
| dc.contributor.author | Anderson, Roger T | |
| dc.contributor.author | Kimmick, Gretchen G | |
| dc.date.accessioned | 2024-02-01T15:10:16Z | |
| dc.date.available | 2024-02-01T15:10:16Z | |
| dc.date.issued | 2015-05 | |
| dc.description.abstract | There are wide disparities in breast cancer-specific survival by patient sociodemographic characteristics. Women of lower income, for instance, have higher relapse and death rates from breast cancer. One possible contributing factor for this disparity is low use of adjuvant endocrine therapy-an extremely efficacious therapy in women with early stage, hormone receptor positive breast cancer, the most common subtype of breast cancer. Alone, adjuvant endocrine therapy decreases breast cancer recurrence by 50% and death by 30%. Data suggest that low use of adjuvant endocrine therapy is a potentially important and modifiable risk factor for poor outcome in low-income breast cancer patients. | |
| dc.identifier.issn | 1540-9996 | |
| dc.identifier.issn | 1931-843X | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Mary Ann Liebert Inc | |
| dc.relation.ispartof | Journal of women's health (2002) | |
| dc.relation.isversionof | 10.1089/jwh.2014.4982 | |
| dc.rights.uri | ||
| dc.subject | Humans | |
| dc.subject | Breast Neoplasms | |
| dc.subject | Neoplasm Recurrence, Local | |
| dc.subject | Tamoxifen | |
| dc.subject | Antineoplastic Agents, Hormonal | |
| dc.subject | Combined Modality Therapy | |
| dc.subject | Chemotherapy, Adjuvant | |
| dc.subject | Poverty | |
| dc.subject | Socioeconomic Factors | |
| dc.subject | Female | |
| dc.subject | Medication Adherence | |
| dc.title | Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Bosworth, Hayden B|0000-0001-6188-9825 | |
| pubs.begin-page | 403 | |
| pubs.end-page | 408 | |
| pubs.issue | 5 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Psychiatry & Behavioral Sciences | |
| pubs.organisational-group | Medicine, General Internal Medicine | |
| pubs.organisational-group | Medicine, Medical Oncology | |
| pubs.organisational-group | Duke Cancer Institute | |
| pubs.organisational-group | Duke Clinical Research Institute | |
| pubs.organisational-group | Institutes and Provost's Academic Units | |
| pubs.organisational-group | Center for the Study of Aging and Human Development | |
| pubs.organisational-group | Initiatives | |
| pubs.organisational-group | Duke Science & Society | |
| pubs.organisational-group | Population Health Sciences | |
| pubs.organisational-group | Duke Innovation & Entrepreneurship | |
| pubs.organisational-group | Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences | |
| pubs.organisational-group | Duke - Margolis Center For Health Policy | |
| pubs.publication-status | Published | |
| pubs.volume | 24 |
Files
Original bundle
- Name:
- ursem-et-al-2015-adherence-to-adjuvant-endocrine-therapy-for-breast-cancer-importance-in-women-with-low-income.pdf
- Size:
- 136.95 KB
- Format:
- Adobe Portable Document Format